Prostate cancer survival is dependent on season of diagnosis
暂无分享,去创建一个
J. Moan | A. Dahlback | J. Berg | T. Beer | A. Porojnicu | Z. Lagunova
[1] J. Moan,et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? , 2007, Lung cancer.
[2] W. Grant. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking , 2006, International journal of cancer.
[3] J. Moan,et al. Changes in risk of death from breast cancer with season and latitude , 2007, Breast Cancer Research and Treatment.
[4] C. Ryan,et al. Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer , 2007, Cancer Chemotherapy and Pharmacology.
[5] D. Neuberg,et al. Polymorphisms of Vitamin D Receptor and Survival in Early-Stage Non–Small Cell Lung Cancer Patients , 2006, Cancer Epidemiology Biomarkers & Prevention.
[6] J. Peto,et al. Cancer survival is dependent on season of diagnosis and sunlight exposure , 2006, International journal of cancer.
[7] A. Kristal,et al. Alcohol Use and the Risk of Prostate Cancer: Results From the VITAL Cohort Study , 2006, Nutrition and cancer.
[8] Gary G. Schwartz,et al. UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States) , 2006, Cancer Causes & Control.
[9] Jorge Yao,et al. 1 a , 25-dihydroxyvitamin D 3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis , 2006 .
[10] M. Fakih,et al. Vitamin D compounds: clinical development as cancer therapy and prevention agents. , 2006, Anticancer research.
[11] Johan Emelian Moan,et al. D-vitaminets fotobiologi – ny aktualitet , 2006 .
[12] Yan Liu,et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.
[13] E. Baldi,et al. Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells , 2006, Steroids.
[14] R. Vieth. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. , 2006, The Journal of nutrition.
[15] B. Armstrong,et al. Variation in Incidence and Fatality of Melanoma by Season of Diagnosis in New South Wales, Australia , 2006, Cancer Epidemiology Biomarkers & Prevention.
[16] E. Baldi,et al. The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells , 2006, Journal of Cancer Research and Clinical Oncology.
[17] J. Colli,et al. International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. , 2005, Urologic oncology.
[18] J. Moan,et al. [The photobiology of vitamin D--a topic of renewed focus]. , 2006, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[19] S. Yeh,et al. 1α,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases , 2005 .
[20] R. Strange,et al. Ultraviolet Radiation, Vitamin D and Risk of Prostate Cancer and Other Diseases , 2005, Photochemistry and photobiology.
[21] D. Neuberg,et al. Vitamin D Is Associated with Improved Survival in Early-Stage Non–Small Cell Lung Cancer Patients , 2005, Cancer Epidemiology Biomarkers & Prevention.
[22] D. Feldman,et al. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[23] T. Beer. ASCENT: The androgen‐independent prostate cancer study of calcitriol enhancing taxotere , 2005, BJU international.
[24] J. Moan,et al. Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D , 2005, British Journal of Cancer.
[25] S. Ingles,et al. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. , 2005, Cancer research.
[26] J. Moan,et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. , 2005, Journal of photochemistry and photobiology. B, Biology.
[27] W. Willett,et al. A prospective study of physical activity and incident and fatal prostate cancer. , 2005, Archives of internal medicine.
[28] T. Beer,et al. Rationale for the development and current status of calcitriol in androgen-independent prostate cancer , 2005, World Journal of Urology.
[29] M. Brustad,et al. Vitamin D status in a rural population of northern Norway with high fish liver consumption , 2004, Public Health Nutrition.
[30] E. Jacobs,et al. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[31] E. John,et al. Residential sunlight exposure is associated with a decreased risk of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[32] E. Giovannucci,et al. Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer , 2004, Cancer Causes & Control.
[33] Johan Moan,et al. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) , 2004, Cancer Causes & Control.
[34] W. Grant. A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. , 2004, European urology.
[35] T. Beer,et al. Calcitriol in cancer treatment: from the lab to the clinic. , 2004, Molecular cancer therapeutics.
[36] M. Holick,et al. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.
[37] William B. Grant,et al. Reviews: A Critical Review of Studies on Vitamin D in Relation to Colorectal Cancer , 2004, Nutrition and cancer.
[38] L. Kolonel,et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) , 1998, Cancer Causes & Control.
[39] Pär Stattin,et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries , 2004, International journal of cancer.
[40] R. Strange,et al. Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation. , 2003, Cancer letters.
[41] R. Strange,et al. Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. , 2003, Carcinogenesis.
[42] R. Strange,et al. Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight. , 2003, Cancer letters.
[43] M. Holick. Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.
[44] M Dosemeci,et al. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study , 2002, Occupational and environmental medicine.
[45] N. Weigel,et al. Vitamin D and Prostate Cancer , 1999, Journal of andrology.
[46] R. Strange,et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer , 2001, The Lancet.
[47] D. Feldman,et al. The role of vitamin D in prostate cancer , 2001, Steroids.
[48] A. Howie,et al. Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .
[49] P M Stewart,et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. , 2001, The Journal of clinical endocrinology and metabolism.
[50] D. Feldman,et al. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration , 2000, Molecular and Cellular Endocrinology.
[51] R. Pandey,et al. Vitamin D: Non-skeletal actions and effects on growth , 1999 .
[52] Gail M. Williams,et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial , 1999, The Lancet.
[53] G. Miller,et al. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[54] M. Horowitz,et al. Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. , 1993, The American journal of clinical nutrition.
[55] J. Moan,et al. Ultraviolet Radiation and Skin Cancer: Epidemiological Data from Scandinavia , 1993 .
[56] J. Moan,et al. The relationship between skin cancers, solar radiation and ozone depletion. , 1992, British Journal of Cancer.
[57] Schwartz Gg,et al. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). , 1990 .
[58] B. Hulka,et al. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). , 1990, Anticancer research.
[59] M. Holick,et al. AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.
[60] J. Moan,et al. Biological amplification factor for sunlight-induced nonmelanoma skin cancer at high latitudes. , 1989, Cancer research.
[61] J. Falch,et al. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein. , 1987, The Journal of clinical endocrinology and metabolism.
[62] M. Holick,et al. Aging Decreases the Capacity of Human Skin to Produce Vitamin D3 , 1986 .
[63] J. Parrish,et al. Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. , 1982, The New England journal of medicine.
[64] N. Breslow,et al. Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France , 1977, International journal of cancer.
[65] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[66] T. V. Rigor. Seasonal and geographical variations in egg production. , 1954 .